| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| W4Y7V3 | Uncharacterized protein; | Sp-Fibcd1; | NULL | 356 | sea-urchin |
| W4YFP3 | Eukaryotic translation initiation factor 3 subunit A; eIF3a; Eukaryotic translation initiation factor 3 subunit 10; | Sp-Eif3a; | NULL | 1282 | sea-urchin |
| W4YLJ1 | Ubiquitin carboxyl-terminal hydrolase; EC 3.4.19.12; | Sp-Usp1; | XP_782306.3; | 825 | sea-urchin |
| W4YGU1 | Uncharacterized protein; | NULL | NULL | 105 | sea-urchin |
| W4XS98 | Uncharacterized protein; | Sp-Polg; | NULL | 1191 | sea-urchin |
| W4Z1M5 | Histone H4; Fragment; | Sp-EhH4_63; | NULL | 92 | sea-urchin |
| W4XEQ3 | Uncharacterized protein; | Sp-Asp; | XP_792768.3; | 380 | sea-urchin |
| W4Z3G4 | Sulfhydryl oxidase; EC 1.8.3.2; | Sp-Qsox1; | NULL | 371 | sea-urchin |
| W4YYR1 | Adenylosuccinate synthetase; AMPSase; AdSS; EC 6.3.4.4; IMP--aspartate ligase; | Sp-Adss2; | NULL | 453 | sea-urchin |
| W4YWY5 | Uncharacterized protein; | Sp-Tbx6/16; | NULL | 316 | sea-urchin |
| W4XJ38 | Uncharacterized protein; | NULL | NULL | 91 | sea-urchin |
| W4XPD4 | Uncharacterized protein; | Sp-Arl2; | NULL | 196 | sea-urchin |
| W4YS63 | Uncharacterized protein; | Sp-Plekhf2; | NULL | 244 | sea-urchin |
| W4Y275 | Uncharacterized protein; | Sp-Opa1L(N-term); | NULL | 398 | sea-urchin |
| W4XS29 | Uncharacterized protein; | Sp-Notchh2; | NULL | 1212 | sea-urchin |
| W4YT83 | Uncharacterized protein; | Sp-Adcy9_1; | NULL | 535 | sea-urchin |
| W4YAB5 | Uncharacterized protein; | Sp-Angptl1L; | NULL | 614 | sea-urchin |
| W4X9K5 | Uncharacterized protein; | Sp-trypL; | NULL | 587 | sea-urchin |
| W4XTX4 | Uncharacterized protein; | Sp-Abcc5B; | NULL | 1347 | sea-urchin |
| W4X9Y3 | Uncharacterized protein; | Sp-Pcsk9l; | NULL | 562 | sea-urchin |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |